The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

The conventional wisdom is that there are two important aspects of timing in investing: when to buy a stock and when to sell ...

By Bharath Rajeswaran BENGALURU (Reuters) -Indian shares recovered from a lacklustre start to end higher on Tuesday, with IT ...

Analyst Mani Foroohar of Leerink Partners maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of ...

BENGALURU (Reuters) - Foreign investors scooped up information technology and pharma stocks in August, which earn a ...

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on ESSA Pharma (EPIX – Research Report), with a price ...

Among individual stocks, Wipro led the Nifty 50 gainers list, rising 3.5 percent driven by high volumes. Over 1 crore shares ...

Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares ...

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look ...

Indian shares opened higher on Tuesday, led by information technology and pharma, and tracking a rebound in global stocks ...

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and ...

[ET Net News Agency, 11 September 2024] HANSOH PHARMA (03692) rose 3% to HK$19.18, breaking above the 20-D SMA of HK$18.908. It hits an intra-day high of HK$19.18, and an intra-day low of HK$18.14.